The present invention relates to a device for protecting an intravenous site of a patient from water and other contaminants during intravenous infusion and more particularly to a device for securing and protecting an intravenous catheter from unwanted and undesired movement thereby significantly decreasing complications and reducing unscheduled catheter restarts.
IV's have become a widely used and standard technique to introduce a substance into a vein of an individual. The substance can be introduced rapidly by an intravenous injection, or slowly by an intravenous infusion. IV's are typically used to introduce or administer blood or plasma during a blood transfusion; a mixture of glucose (sugar) and saline (salt) or other varied or concentrated nutrients for artificial feeding or hydration; and various drugs or medicines to treat pain, illness or disease.
IV's are typically comprised of a bag or bottle, a tube and a cannula. The bag or bottle store and contain the substance that is to be administered to the individual and is suspended from a holder above the insertion point of the IV. The tube is generally made of clear plastic for easy examination. The tube is connected at one end to the bag or bottle suspended from the holder. The opposite end of the tube is connected to the cannula. The cannula is inserted into the vein of the individual through the skin at the insertion point. After the cannula is inserted into the vein and connected to the tube, it is generally secured in place by surgical tape to the skin surrounding the insertion point. The cannula is secured in place to prevent damage which could otherwise result from its movement relative to the vein or insertion point through the skin.
An intravenous catheter can be dangerous if not properly secured—dangerous to both the patient and the healthcare worker. Taping the intravenous catheter to the skin of the patient is not an acceptable solution, as tape is not designed to secure a catheter. Moreover, tape allows micro-movement of a catheter which in turn can result in complications, including phlebitis, infiltration, extravasations, dislodgement, disconnection, and even infection. Such complications necessitate unscheduled catheter restarts—which expose healthcare workers to dangerous blood-filled stylets and needles.
An improper angle of insertion can also be dangerous to the patient and can lead to complications such as those described above, particularly phlebitis. Not all insertion sites have the same amount of tissue or flesh surrounding a vein. Therefore, applicant has discovered that a uniform angle of insertion for all sites is not an optimal solution. Moreover, improper insertion angle is difficult to remedy with current application methods.
Therefore it would be highly desirable to have a new and improved device and method for securing an intravenous catheter from unwanted and undesired movement thereby significantly decreasing complications and reducing unscheduled catheter restarts.
In accordance with one embodiment, there is provided a venipuncture site protector that includes a securement, a cover mounted on the securement, and an internal wall that divides the cover into a catheter receiving portion and a tube receiving portion. The internal wall includes a tube access channel. The cover includes a proximal end having a front wall with a tube receiving slot. The cover also includes a distal end that forms an arch. The tube receiving slot and tube access channel are in substantial alignment with one another.
In accordance with another embodiment, there is provided a venipuncture site protector that includes a securement and a cover mounted to said securement. The cover includes a proximal end having a front wall with a tube receiving slot. The cover also includes a distal end having an arch that forms an opening that lies on a vertical plane that is substantially perpendicular to the securement.
The above mentioned features and steps of the invention and the manner of attaining them will become apparent, and the invention itself will be best understood by reference to the following description of the embodiments of the invention in conjunction with the accompanying drawings wherein:
Before discussing the preferred embodiment of the present invention, it may be helpful to first briefly review the basic devices and concepts used in the administration of fluids and or medications directly into a venous system of a patient, which is otherwise called, intravenous therapy, or simply I.V. therapy.
The most common method of administering I.V. fluids is with an I.V. catheter 8, which generally comprises a catheter C, a needle (not shown), and a catheter head or flashback chamber H which is adapted to be connected to an I.V. set and its associated I.V. tubing T by a luer nut arrangement L. The flowing of blood into the flashback chamber H provides an I.V. technician with a visual indication of a successful venous entry.
In use the I.V. technician selects a venous access site, which typically will be the top surface area of a patient's hand as best seen in
The I.V. technician then attaches an I.V. fluid set (not shown) and more particularly, the I.V. tubing T to the catheter head H using the luer lock nut arrangement L disposed at the distal end of the I.V. tubing T. The luer lock nut arrangement L includes a catheter connector 9 that is secured to the distal end of the tubing T and which is adapted to be inserted into the flashback chamber H and then locked into a fluid tight seal with a rotatable nut N that slide along the outer surface of the catheter connector 9. In this regard, the connector 9 is inserted into the flashback chamber H and the nut N is pushed along the connector 9 and onto the proximal end of the head H. With the nut N so positioned against the head H, the nut N is rotated into locking engagement. In this process, the I.V. tubing T is connected in a fluid tight seal with the catheter C to facilitate the administration of fluid therapy.
It should be understood by those skilled in the art that the I.V. connector 9 and I.V. catheter 8 are standardized relative to relative to size and overall length. This standardization of size and length is important relative to the preferred embodiment of the present invention as will be explained hereinafter in greater detail.
Referring now to the drawings and more particularly to
Considering now the venipuncture site protector 10 in greater detail with reference to
The body member 14 as best seen in
The flanges 22A and 22B each has a distal portion 40A and 40B and a proximal portion 42A and 42B respectively, which proximal portions 42A and 42B converge to form a tube access slot 44 that is in alignment with another tube access slot 13 that is disposed in a proximal portion of the securement 12.
The vault 24 is generally trapezoidal or pentagonal in a side elevational view (
Depending perpendicularly downwardly from the ceiling of the sloped proximal wall 30 is an internal wall 18 whose side peripheral edges are integrally connected to an interior surface portion of the sloped proximal wall 30. The internal wall 18 divides or partitions the interior space of the body member 14 into a distal portion or I.V. connected catheter receiving compartment or portion 15 and a proximal space or I.V. tube receiving portion or compartment 16. The internal wall 18 includes a centrally disposed tube receiving slot 19 that terminates at its upper end in a tube receiving stop 20, which is generally circular, and dimensioned for receiving therein the tubing T of the I.V. set. As best seen in
Considering now the securement 12 in greater detail with reference to
In one embodiment, as shown in
In another embodiment, as shown in
The protective covers 17 and 104A and 104B are removable and are provided to protect the adhesive surfaces 136A and 136B and 102A and 102B respectively until such time as the securement 120 is ready to be utilized with a patient. It will suffice for the moment to mention that the securement 12 is initially or partially secured to the venipuncture site 11 by removing the cover 17 and pressing the adhesive layers 136A and 136B against the skin of the patient and then after the I.V. connected catheter has been secured within the vault 24, the securement 12 is fixed in placed by removing the covers 104A and 104B to press the uncovered adhesive surfaces 102A and 102B against the skin of the patient. This is an important feature of this embodiment of the present invention, as this allows the site protector 10 to remain in place for extended periods of time thereby greatly reducing the risk of exposing healthcare workers to dangerous blood-filled stylets and needles.
Considering now the novel method of using the site protector 10, as best seen in FIGS. 21 and 24-25, a healthcare provider such as a doctor or a nurse creates a venipuncture site 11 by using an I.V. catheter 8 to insert the catheter C into the vein of a patient.
The I.V. set tubing T is then connected in a fluid tight seal with the catheter C to facilitate the administration of fluid therapy in the manner as previously described. More particularly, the healthcare provider attaches the I.V. set tubing T to the catheter 8 by sliding the nut N along the plastic connector 9 and into engagement with the head H. The nut is then rotated to lock the I.V. set tubing T to the catheter 8 as been seen in
With the I.V. set tubing T so attached to the catheter 8, the healthcare provider removes the sheet of protective covering 17 from the underside of the securement 12 to provide access to the interior of the cover 14.
Next, the vault 24 is positioned over the venipuncture site 11 in an aligned manner so that the connector 9 is disposed within the proximal portion 15 and against the partition or interior wall 18 and the I.V. set tubing T aligned in the tube access slot 13 of the securement 12, the tube receiving stop 52 of the front wall 30 and the tube receiving slot 19 of the internal wall 18. With the vault 24 and the tubing T so aligned, the vault 24 of the site protector 10 is pressed against the skin of the patient. In this regard, the unprotected adhesive surfaces 136A and 136B uncovered when the cover 17 was removed secures the site protector 10 to the skin of the patient.
Next as best seen in
As best seen in
The health care provider then repeats the above mentioned procedure by lifting the other one of the wings 120A or 120B upward a sufficient distance so the remaining portion of the protective cover 104A or 104B disposed on the underside of the wing 120A or 120B can also be peeled away to expose the adhesive layer 102A or 102B. The other lifted wing 120A or 120B is then pressed downward onto the skin of the patient to further secure the site protector 10 to the patient.
From the foregoing, it should be understood by those skilled in the art, that I.V. connected catheter is disposed in the distal portion 15 of the site protector 10 and completely immobilized therein due do the friction tight engagement of the connector 9 with the interior wall 18 and the capturing of the I.V. tubing T within the tube receiving slot 19. In this regard, the tubing T cannot be dislodged from the site protector 10 except by exerting a sufficiently strong downward pulling action to dislodge the tubing T from both stops 20 and 52 so the tubing T can enter the slots 44 and 19, which in turn continue to exert a strong frictional resistance against the tubing so that dislodging the connector 9 from interior wall 18 and the front wall 30 is extremely difficult if not entirely impossible, unless the site protector 10 is first removed from the skin of the patient so the tubing T can first be pulled downward through the tube access slot 13 of the securement 12.
As a final step, as best seen in
Considering now the venipuncture protector 10 in still greater detail, as best seen in
Covering the distal portion is a vault 24. The distal end of the vault culminates in an arch 27 forming an opening 28. The proximal end of the vault 24 is integrally formed with the wall 30, which slopes downward from the proximal end of the vault 24 towards the securement 12 at an angle α relative to the securement. In one embodiment, the angle α is between about 30° and about 70°. In another embodiment, the angle is between about 40° and about 60°. In yet another embodiment, the angle is about 50°.
As shown in
The opening 28 is formed by the arch 27. The opening 28 lies on a vertical plane that is substantially perpendicular to the securement 12 and the flanges 22A and 22B when the securement and flanges lie on a horizontal plane.
Another important feature of this embodiment of the present invention is that the roof of the vault 24 is high enough to accommodate typical catheter bodies. As mentioned earlier, the overall length, height and width dimensions of an I.V. connected catheter are standardized in the medical industry. In one embodiment, the height of the vault from the roof of the vault to the flanges 22A and 22B and securement 12 is between about 10 mm and about 20 mm. In another embodiment, the height of the vault is between about 12 mm and about 18 mm. In another embodiment, the height of the vault is about 15 mm. Also, the roof of the vault is substantially parallel with the flanges 22A and 22B and the securement 12 when the securement is in a horizontal plane. The length of the distal catheter receiving portion 15 is between about 15 mm and about 25 mm in one embodiment, between about 18 mm and about 22 mm in another embodiment, and between about 19 mm and about 20 mm in yet another embodiment.
Considering now the method of making the venipuncture protector 10 with reference to
Next, the lower surface area of the sheet of plastic material 100 is coated with a thin layer of non-skin irritating adhesive 102, which in turn, is immediately covered with a thin sheet of covering material 104. The covering material 104 is selected to have a surface area that corresponds to the surface area of the thin sheet of plastic material 100 and is provided to protect the adhesive 102 from exposure to objects during the manufacturing process.
The prepared sheet of stock material 110 is then stamp cut into any one of the desired securement shapes previously mentioned or any other shape that would be desired. For example the prepared sheet of stock material 110 is stamp cut into a dual winged shape to form a securement base 120 as best seen in
The process of making the dual wing shaped securement base 120 begins by first cutting the sheet of prepared material 110 into an overall desired securement pattern of dual wings 120A and 120B, such as best seen in
Next a plurality of aeration holes are stamp cut through the sheet of stock material 110. The aeration holes are equally spaced apart and positioned to be at about adjacent each of the corners of the wings 120A and 120B. Although the method of preparing the wings 120A and 120B with the holes has been described in individual stamp cutting steps, those skilled in the art will appreciate that the dual wing shaped base 120 can be prepare in a single stamp process as well.
Next, as illustrated in
As best seen in
Next another sheet of stock material 150 having two adhesive surfaces with each surface being protected by a wax paper covering is provided. In this regard, the sheet of stock material 150 is prepared by providing a thin sheet of plastic material 130 having an upper surface area and a lower surface area as best seen in
Next, the lower surface area of the sheet of plastic material 130 is coated with a thin layer of adhesive 132, which in turn, is immediately covered with a thin sheet of covering material 134. The covering material 134 is selected to have a surface area that corresponds to the surface area of the thin sheet of plastic material 130 and is provided to protect the adhesive 132 from exposure to objects during the manufacturing process.
Next, the upper surface area of the sheet of plastic material 130 is coated with a thin layer of adhesive 136, which in turn, is immediately covered with a thin sheet of covering material 138. The covering material 138 is selected to have a surface area that corresponds to the surface area of the thin sheet of plastic material 130 and is provided to protect the adhesive 136 from exposure to objects during the manufacturing process.
The prepared sheet of stock material 150 is then stamp cut into a two piece plug 160A and 160B (
Next as best seen in
The plug 160A and 160B is then again inverted as best seen in
Next, as best seen in
As best seen in
As best seen in
Referring now to the drawings and more particularly to
Referring now to the drawings and more particularly to
While particular embodiments of the present invention have been disclosed, it is to be understood that various different modifications are possible and are contemplated within the true spirit and scope of the appended claims. There is no intention, therefore, of limitations to the exact abstract or disclosure herein presented.
Number | Name | Date | Kind |
---|---|---|---|
695270 | Beringer | Mar 1902 | A |
1706634 | Seils | Mar 1928 | A |
2008340 | Salvati et al. | Jul 1935 | A |
2367690 | Purdy | Jul 1943 | A |
2402306 | Turkel | Jun 1946 | A |
3046984 | Eby | Jul 1962 | A |
3194235 | Cooke | Jul 1965 | A |
3461869 | Hargest | Aug 1969 | A |
3537452 | Wilks | Nov 1970 | A |
3568679 | Reif | Mar 1971 | A |
3630195 | Santomieri | Dec 1971 | A |
3640275 | Burke et al. | Feb 1972 | A |
3782383 | Thompson et al. | Jan 1974 | A |
3826254 | Mellor | Jul 1974 | A |
3900026 | Wagner | Aug 1975 | A |
3901226 | Scardenzan | Aug 1975 | A |
3910538 | Baitella | Oct 1975 | A |
4059105 | Cutruzzula et al. | Nov 1977 | A |
4082094 | Dailey | Apr 1978 | A |
4129128 | McFarlane | Dec 1978 | A |
D252822 | McFarlane | Sep 1979 | S |
4193174 | Stephens | Mar 1980 | A |
4224937 | Gordon | Sep 1980 | A |
4250880 | Gordon | Feb 1981 | A |
4277102 | Aras | Jul 1981 | A |
4316461 | Marais et al. | Feb 1982 | A |
4333468 | Geist | Jun 1982 | A |
4470410 | Elliott | Sep 1984 | A |
4484913 | Swauger | Nov 1984 | A |
4516968 | Marshall et al. | May 1985 | A |
4517971 | Sorbonne | May 1985 | A |
4563177 | Kamen | Jan 1986 | A |
4585443 | Kaufman | Apr 1986 | A |
4627842 | Katz | Dec 1986 | A |
4632670 | Muller | Dec 1986 | A |
4633863 | Filips et al. | Jan 1987 | A |
4645492 | Weeks | Feb 1987 | A |
4666434 | Kaufman | May 1987 | A |
4667666 | Fryslie | May 1987 | A |
4669458 | Abraham | Jun 1987 | A |
4679553 | Proulx | Jul 1987 | A |
4711636 | Bierman | Dec 1987 | A |
4737143 | Russell | Apr 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4846807 | Safadago | Jul 1989 | A |
4852844 | Villaveces | Aug 1989 | A |
4863432 | Kvalo | Sep 1989 | A |
4870976 | Denny | Oct 1989 | A |
4878897 | Katzin | Nov 1989 | A |
4898587 | Mera | Feb 1990 | A |
4913393 | Wood | Apr 1990 | A |
4976698 | Stokley | Dec 1990 | A |
4997421 | Palsrok et al. | Mar 1991 | A |
5029941 | Twisselmann | Jul 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5074847 | Greenwell et al. | Dec 1991 | A |
5084026 | Shapiro | Jan 1992 | A |
5112313 | Sallee | May 1992 | A |
5116324 | Brierley et al. | May 1992 | A |
5137519 | Littrell et al. | Aug 1992 | A |
5167240 | Rozier et al. | Dec 1992 | A |
5192273 | Bierman | Mar 1993 | A |
5192274 | Bierman | Mar 1993 | A |
5215532 | Atkinson | Jun 1993 | A |
5230350 | Fentress | Jul 1993 | A |
5238010 | Grabenkort | Aug 1993 | A |
5281001 | Bergsten et al. | Jan 1994 | A |
5290248 | Bierman et al. | Mar 1994 | A |
D347060 | Bierman | May 1994 | S |
5314411 | Bierman et al. | May 1994 | A |
5328487 | Starchevich | Jul 1994 | A |
5339834 | Marcelli | Aug 1994 | A |
5354282 | Bierman | Oct 1994 | A |
5356391 | Stewart | Oct 1994 | A |
5370627 | Conway | Dec 1994 | A |
5395344 | Beisang et al. | Mar 1995 | A |
5407249 | Bonutti | Apr 1995 | A |
5413120 | Grant | May 1995 | A |
5413562 | Swauger | May 1995 | A |
D359120 | Sallee et al. | Jun 1995 | S |
5449349 | Sallee et al. | Sep 1995 | A |
D363543 | Van Funderburk et al. | Oct 1995 | S |
5456671 | Bierman | Oct 1995 | A |
5462247 | Aldrich | Oct 1995 | A |
D364922 | Bierman | Dec 1995 | S |
5480719 | Tollini | Jan 1996 | A |
D375355 | Bierman | Nov 1996 | S |
D375356 | Bierman | Nov 1996 | S |
5577516 | Schaeffer | Nov 1996 | A |
5578013 | Bierman | Nov 1996 | A |
D377125 | Adamsson | Jan 1997 | S |
D377831 | Bierman | Feb 1997 | S |
5605546 | Wolzinger et al. | Feb 1997 | A |
5664581 | Ashley | Sep 1997 | A |
5681290 | Alexander | Oct 1997 | A |
5685859 | Kornerup | Nov 1997 | A |
5686096 | Khan et al. | Nov 1997 | A |
5690616 | Mogg | Nov 1997 | A |
5693032 | Bierman | Dec 1997 | A |
5702371 | Bierman | Dec 1997 | A |
5713591 | Zarkhin et al. | Feb 1998 | A |
5722959 | Bierman | Mar 1998 | A |
5728053 | Calvert | Mar 1998 | A |
5733571 | Sackler | Mar 1998 | A |
5776106 | Matyas | Jul 1998 | A |
5800402 | Bierman | Sep 1998 | A |
5800410 | Gawreluk | Sep 1998 | A |
5810781 | Bierman | Sep 1998 | A |
D399954 | Bierman | Oct 1998 | S |
5827230 | Bierman | Oct 1998 | A |
5827239 | Dillon et al. | Oct 1998 | A |
D401330 | Wright-Owens | Nov 1998 | S |
5833666 | Davis et al. | Nov 1998 | A |
5833667 | Bierman | Nov 1998 | A |
5855591 | Bierman | Jan 1999 | A |
5885254 | Matyas | Mar 1999 | A |
5897519 | Shesol et al. | Apr 1999 | A |
6050934 | Mikhail et al. | Apr 2000 | A |
D425619 | Bierman | May 2000 | S |
6096943 | Maiwald | Aug 2000 | A |
6099509 | Brown et al. | Aug 2000 | A |
6113577 | Hakky et al. | Sep 2000 | A |
6123690 | Mejslov | Sep 2000 | A |
6132398 | Bierman | Oct 2000 | A |
6132399 | Shultz | Oct 2000 | A |
6213979 | Bierman | Apr 2001 | B1 |
6224571 | Bierman | May 2001 | B1 |
6231547 | O'Hara | May 2001 | B1 |
6231548 | Bassett | May 2001 | B1 |
6241697 | Augustine | Jun 2001 | B1 |
6255552 | Cummings et al. | Jul 2001 | B1 |
6258066 | Urich | Jul 2001 | B1 |
6264977 | Hoffmann | Jul 2001 | B1 |
6283945 | Bierman | Sep 2001 | B1 |
6290676 | Bierman | Sep 2001 | B1 |
6322539 | Cook | Nov 2001 | B1 |
6332874 | Eliasen et al. | Dec 2001 | B1 |
6361523 | Bierman | Mar 2002 | B1 |
6375639 | Duplessie | Apr 2002 | B1 |
6413240 | Bierman | Jul 2002 | B1 |
6428515 | Bierman | Aug 2002 | B1 |
6428516 | Bierman | Aug 2002 | B1 |
6436073 | Teichert | Aug 2002 | B1 |
6447485 | Bierman | Sep 2002 | B2 |
6447486 | Tollini | Sep 2002 | B1 |
6458104 | Gautsche | Oct 2002 | B2 |
6471676 | DeLegge et al. | Oct 2002 | B1 |
6482183 | Pausch | Nov 2002 | B1 |
6491664 | Bierman | Dec 2002 | B2 |
6500154 | Hakky et al. | Dec 2002 | B1 |
D469530 | Gomez | Jan 2003 | S |
D470936 | Bierman | Feb 2003 | S |
6517522 | Bell et al. | Feb 2003 | B1 |
6526981 | Rozier et al. | Mar 2003 | B1 |
6551285 | Bierman | Apr 2003 | B1 |
6572588 | Bierman et al. | Jun 2003 | B1 |
6582403 | Bierman et al. | Jun 2003 | B1 |
6616635 | Bell et al. | Sep 2003 | B1 |
6619598 | De Miranda | Sep 2003 | B2 |
6619747 | Ko et al. | Sep 2003 | B2 |
6626890 | Nguyen et al. | Sep 2003 | B2 |
6652487 | Cook | Nov 2003 | B1 |
6663600 | Bierman et al. | Dec 2003 | B2 |
6689104 | Bierman | Feb 2004 | B2 |
D492411 | Bierman | Jun 2004 | S |
6770055 | Bierman et al. | Aug 2004 | B2 |
6786892 | Bierman | Sep 2004 | B2 |
6809230 | Hancock et al. | Oct 2004 | B2 |
6827705 | Bierman | Dec 2004 | B2 |
6827706 | Tollini | Dec 2004 | B2 |
6827707 | Wright et al. | Dec 2004 | B2 |
6834652 | Altman | Dec 2004 | B2 |
6837875 | Bierman | Jan 2005 | B1 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6866652 | Bierman | Mar 2005 | B2 |
D503977 | Bierman | Apr 2005 | S |
6951550 | Bierman | Oct 2005 | B2 |
6972003 | Bierman | Dec 2005 | B2 |
6979320 | Bierman | Dec 2005 | B2 |
6981969 | Chavez et al. | Jan 2006 | B2 |
7014627 | Bierman | Mar 2006 | B2 |
7018362 | Bierman | Mar 2006 | B2 |
7070580 | Nielsen | Jul 2006 | B2 |
7090660 | Roberts et al. | Aug 2006 | B2 |
D528206 | Bierman | Sep 2006 | S |
7153291 | Bierman | Dec 2006 | B2 |
7155287 | Gavronsky | Dec 2006 | B2 |
7354421 | Bierman | Apr 2008 | B2 |
20010011164 | Bierman | Aug 2001 | A1 |
20020068904 | Bierman et al. | Jun 2002 | A1 |
20020099360 | Bierman | Jul 2002 | A1 |
20030055382 | Schaeffer | Mar 2003 | A1 |
20030069529 | Augustine et al. | Apr 2003 | A1 |
20030229313 | Bierman | Dec 2003 | A1 |
20040102736 | Bierman | May 2004 | A1 |
20040111067 | Kirchhofer | Jun 2004 | A1 |
20040138624 | Bierman | Jul 2004 | A1 |
20040143220 | Worthley | Jul 2004 | A1 |
20040158209 | Wright | Aug 2004 | A1 |
20040204685 | Wright et al. | Oct 2004 | A1 |
20050182367 | Walborn | Aug 2005 | A1 |
20050215953 | Rossen | Sep 2005 | A1 |
20050288635 | Davis et al. | Dec 2005 | A1 |
20060015076 | Heinzerling et al. | Jan 2006 | A1 |
20060064063 | Bierman | Mar 2006 | A1 |
20060135944 | Bierman | Jun 2006 | A1 |
20060184127 | Bierman | Aug 2006 | A1 |
20060184129 | Bierman | Aug 2006 | A1 |
20060217669 | Botha | Sep 2006 | A1 |
20060247577 | Wright | Nov 2006 | A1 |
20060264836 | Bierman | Nov 2006 | A1 |
20060270995 | Bierman | Nov 2006 | A1 |
20090048563 | Ethelfeld et al. | Feb 2009 | A1 |
Number | Date | Country |
---|---|---|
1 311 977 | Dec 1992 | CA |
1 318 824 | Jun 1993 | CA |
0356683 | Mar 1990 | EP |
0356683 | Mar 2000 | EP |
WO 9421319 | Sep 1994 | WO |
WO 9715337 | May 1997 | WO |
WO 9955409 | Nov 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20060247577 A1 | Nov 2006 | US |